An Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in Subjects Diagnosed With Epilepsy
Abroad (travel likely)RecruitingPHASE2
Conditions
Focal Epilepsy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Alfred Health, Melbourne, Victoria, Australia